Electrocardiographic Abnormalities Predicting Mortality in COVID-19 Pneumonia Patients

Overview

Journal J Family Med Prim Care

Specialty Public Health

Date 2022 Jul 8

PMID 35800531

Authors

Nidhi Kaeley

Prakash Mahala

Rohit Walia

Affiliations

Soon will be listed here.

Abstract

Background: Cardiovascular involvement is a significant cause of death in COVID pneumonia. Early electrocardiographic changes may predict cardiovascular involvement and predict mortality in COVID pneumonia patients.

Methods: A total of 250 consecutive patients with COVID-19 pneumonia admitted to the emergency were studied for electrocardiographic abnormalities and their relation to mortality.

Results: Most patients required supplemental oxygen to maintain optimal saturation. A total of 72% showed ECG abnormalities, and the overall cohort had a mortality of 50%. New-onset atrial fibrillation, left bundle branch block or right bundle branch pattern, and ventricular premature complexes were associated with high mortality. Sinus tachycardia and atrial fibrillation were the most common arrhythmia and were significantly associated with mortality.

Conclusions: New-onset atrial fibrillation, intraventricular conduction defects, and sinus tachycardia are associated with increased mortality in COVID pneumonia patients.

Citing Articles

Relationship of Right and Left Bundle Branch Blocks to Mortality in COVID-19 Patients Hospitalized in the Intensive Care Unit: a Descriptive-Analytical Retrospective Study.

Bahrami S, Alshargabi B, Monajem M, Jiryaei N, Karkhanei B Maedica (Bucur). 2025; 19(4):726-730.

PMID: 39974453 PMC: 11834852. DOI: 10.26574/maedica.2024.19.4.726.

Association of electrocardiographic abnormalities and COVID-19 clinical outcomes.

Jabbari L, Hayati S, Azizkhani L, Tavakol J J Electrocardiol. 2023; 78:76-79.

PMID: 36863119 PMC: 9951026. DOI: 10.1016/j.jelectrocard.2023.02.002.

References

Ali A, Boutjdir M, Aromolaran A . Cardiolipotoxicity, Inflammation, and Arrhythmias: Role for Interleukin-6 Molecular Mechanisms. Front Physiol. 2019; 9:1866. PMC: 6330352. DOI: 10.3389/fphys.2018.01866. View

Akhmerov A, Marban E . COVID-19 and the Heart. Circ Res. 2020; 126(10):1443-1455. DOI: 10.1161/CIRCRESAHA.120.317055. View

McCullough S, Goyal P, Krishnan U, Choi J, Safford M, Okin P . Electrocardiographic Findings in Coronavirus Disease-19: Insights on Mortality and Underlying Myocardial Processes. J Card Fail. 2020; 26(7):626-632. PMC: 7293518. DOI: 10.1016/j.cardfail.2020.06.005. View

Aviles R, Martin D, Apperson-Hansen C, Houghtaling P, Rautaharju P, Kronmal R . Inflammation as a risk factor for atrial fibrillation. Circulation. 2003; 108(24):3006-10. DOI: 10.1161/01.CIR.0000103131.70301.4F. View

Ter Keurs H, Boyden P . Calcium and arrhythmogenesis. Physiol Rev. 2007; 87(2):457-506. PMC: 4332537. DOI: 10.1152/physrev.00011.2006. View

Rautaharju P, Surawicz B, Gettes L, Bailey J, Childers R, Deal B . AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part IV: the ST segment, T and U waves, and the QT interval: a scientific statement from the American Heart Association Electrocardiography and.... Circulation. 2009; 119(10):e241-50. DOI: 10.1161/CIRCULATIONAHA.108.191096. View

Colon C, Barrios J, Chiles J, McElwee S, Russell D, Maddox W . Atrial Arrhythmias in COVID-19 Patients. JACC Clin Electrophysiol. 2020; 6(9):1189-1190. PMC: 7253953. DOI: 10.1016/j.jacep.2020.05.015. View

Amdur R, Mukherjee M, Go A, Barrows I, Ramezani A, Shoji J . Interleukin-6 Is a Risk Factor for Atrial Fibrillation in Chronic Kidney Disease: Findings from the CRIC Study. PLoS One. 2016; 11(2):e0148189. PMC: 4739587. DOI: 10.1371/journal.pone.0148189. View

Wagner G, MacFarlane P, Wellens H, Josephson M, Mirvis D, Pahlm O . AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part VI: acute ischemia/infarction: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council.... J Am Coll Cardiol. 2009; 53(11):1003-11. DOI: 10.1016/j.jacc.2008.12.016. View

10.

Seguin P, Launey Y . Atrial fibrillation is not just an artefact in the ICU. Crit Care. 2010; 14(4):182. PMC: 2945089. DOI: 10.1186/cc9093. View

11.

Fried J, Ramasubbu K, Bhatt R, Topkara V, Clerkin K, Horn E . The Variety of Cardiovascular Presentations of COVID-19. Circulation. 2020; 141(23):1930-1936. PMC: 7314498. DOI: 10.1161/CIRCULATIONAHA.120.047164. View

12.

Walkey A, Wiener R, Ghobrial J, Curtis L, Benjamin E . Incident stroke and mortality associated with new-onset atrial fibrillation in patients hospitalized with severe sepsis. JAMA. 2011; 306(20):2248-54. PMC: 3408087. DOI: 10.1001/jama.2011.1615. View

13.

Leibovici L, Gafter-Gvili A, Paul M, Almanasreh N, Tacconelli E, Andreassen S . Relative tachycardia in patients with sepsis: an independent risk factor for mortality. QJM. 2007; 100(10):629-34. DOI: 10.1093/qjmed/hcm074. View

14.

Kuipers S, Klein Klouwenberg P, Cremer O . Incidence, risk factors and outcomes of new-onset atrial fibrillation in patients with sepsis: a systematic review. Crit Care. 2014; 18(6):688. PMC: 4296551. DOI: 10.1186/s13054-014-0688-5. View

15.

Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F . Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA Cardiol. 2020; 5(7):802-810. PMC: 7097841. DOI: 10.1001/jamacardio.2020.0950. View

16.

Wang Y, Chen L, Wang J, He X, Huang F, Chen J . Electrocardiogram analysis of patients with different types of COVID-19. Ann Noninvasive Electrocardiol. 2020; 25(6):e12806. PMC: 7536962. DOI: 10.1111/anec.12806. View

17.

Aulin J, Siegbahn A, Hijazi Z, Ezekowitz M, Andersson U, Connolly S . Interleukin-6 and C-reactive protein and risk for death and cardiovascular events in patients with atrial fibrillation. Am Heart J. 2015; 170(6):1151-60. DOI: 10.1016/j.ahj.2015.09.018. View

18.

Angeli F, Spanevello A, De Ponti R, Visca D, Marazzato J, Palmiotto G . Electrocardiographic features of patients with COVID-19 pneumonia. Eur J Intern Med. 2020; 78:101-106. PMC: 7305928. DOI: 10.1016/j.ejim.2020.06.015. View

19.

Otake H, Suzuki H, Honda T, Maruyama Y . Influences of autonomic nervous system on atrial arrhythmogenic substrates and the incidence of atrial fibrillation in diabetic heart. Int Heart J. 2009; 50(5):627-41. DOI: 10.1536/ihj.50.627. View

20.

Stone E, Kiat H, McLachlan C . Atrial fibrillation in COVID-19: A review of possible mechanisms. FASEB J. 2020; 34(9):11347-11354. DOI: 10.1096/fj.202001613. View